The Europe Peripheral Vascular Stents Market would witness market growth of 7.1% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 467.7 thousand units, showcasing a growth of 6.6% (2019-2022).
Stents are also used to treat peripheral arterial aneurysms, which are weak areas or bulges in blood vessel walls. Stent grafts can be inserted to reinforce the weakened vessel and prevent rupture. In many cases, these stents provide a less invasive alternative to traditional surgical procedures. This minimizes the risks associated with surgery, reduces hospitalization time, and speeds up recovery. Stenosis, or the narrowing of blood vessels, can occur in various peripheral arteries, including those in the legs, arms, and neck. Stents are necessary to widen these narrowed vessels and maintain blood flow. In cases of critical limb ischemia, where blood flow to the limbs is severely compromised, peripheral vascular stents are a crucial treatment option to prevent limb loss and improve patient outcomes.
Drug-eluting stents (DES), which release medication over time to prevent restenosis (re-narrowing of the blood vessel), rise. DES is becoming increasingly popular due to its ability to improve long-term outcomes and reduce the need for repeat procedures. Bioabsorbable stents, designed to dissolve gradually in the body after they've served their purpose, gaining attention.
As per the UK government’s report named “Future of an Ageing Population,” by 2040, nearly one in seven people are projected to be over 75 in the UK. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The proportion of the working-age population between 50 and the state pension age (SPA) will rise 34% in 2050 compared to 26% in 2012, a rise of more than 5.5 million people. The abovementioned factors will aid in the expansion of the market in the coming years.
The Germany market dominated the Europe Peripheral Vascular Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $175.9 million by 2030. The UK market is exhibiting a CAGR of 6.2% during (2023 - 2030). Additionally, The France market would experience a CAGR of 7.9% during (2023 - 2030).
Based on Mode of Delivery, the market is segmented into Balloon-expandable Stents, and Self-expanding Stents. Based on End-use, the market is segmented into Hospitals & Cardiac Centers, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, and Others. Based on Stents Type, the market is segmented into Drug Eluting Stents (DES), Bare Metal Stents (BMS), and Bioabsorbable Stents. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Peripheral Vascular Stents Market will Hit $2.7 Billion by 2030, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Abbott Laboratories, Biotronik SE & Co. KG, Stryker Corporation, Cook Medical, Inc. (Cook Group), MicroPort Scientific Corporation, LifeTech Scientific Corporation and iVascular S.L.U.
By Mode of Delivery (Volume, Thousand Units, USD Million, 2019-2030)
By End-use (Volume, Thousand Units, USD Million, 2019-2030)
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By Stents Type (Volume, Thousand Units, USD Million, 2019-2030)
By Country (Volume, Thousand Units, USD Million, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
